Is Wave Life Stock a Good Investment?
Wave Life Investment Advice | WVE |
- Examine Wave Life's financial health by looking at its balance sheet, income statement, and cash flow statement. Analyze key financial ratios, such as Price-to-Earnings (P/E), Price-to-Sales (P/S), and Price-to-Book (P/B), to determine whether the stock is fairly valued or over/undervalued.
- Research Wave Life's leadership team and their track record. Good management can help Wave Life navigate difficult times and make strategic decisions that benefit shareholders and increases its net worth.
- Consider the overall health of the Pharmaceuticals space and any emerging trends that could impact Wave Life's business and its evolving consumer preferences.
- Compare Wave Life's performance and market position to its competitors. Analyze how Wave Life is positioned in terms of product offerings, innovation, and market share.
- Check if Wave Life pays a dividend and its dividend yield and payout ratio.
- Review what financial analysts are saying about Wave Life's stock and their price targets. However, remember that analysts' opinions can vary, and their predictions may not always be accurate.
It's important to note that investing in Wave Life Sciences stock, carries risks, and you should carefully consider your investment goals and risk tolerance before making any investment decisions. Also, remember that it's important for investors to have a long-term perspective and a well-diversified portfolio to manage the impact of stock market volatility on their investments. Below is a detailed guide on how to decide if Wave Life Sciences is a good investment.
Sell | Buy |
Buy
Market Performance | Good | Details | |
Volatility | Relatively risky | Details | |
Hype Condition | Under hyped | Details | |
Current Valuation | Overvalued | Details | |
Odds Of Distress | Low | Details | |
Economic Sensitivity | Hyperactively responds to market trends | Details | |
Investor Sentiment | Impartial | Details | |
Analyst Consensus | Strong Buy | Details | |
Financial Strenth (F Score) | Poor | Details | |
Financial Leverage | Not Rated | Details | |
Reporting Quality (M-Score) | Unlikely Manipulator | Details |
Examine Wave Life Stock
Researching Wave Life's stock involves analyzing various aspects of the company and its industry to make an informed investment decision. The key areas to focus on are fundamentals, business model and competitive advantage. It is also important to analyze trends in revenue, net income, and cash flow, as well as key financial ratios, such as price-to-earnings (P/E), price-to-sales (P/S), and debt-to-equity (D/E). About 15.0% of the company outstanding shares are owned by insiders. The company recorded a loss per share of 1.12. Wave Life Sciences had not issued any dividends in recent years.
To determine if Wave Life is a good investment, evaluating the company's potential for future growth is also very important. This may include expanding into new markets, launching new products or services, or improving operational efficiency. Companies with strong growth prospects can be more attractive investments. This aspect of the research should be conducted in the context of the overall market and industry in which the company operates and should include an analysis of growth potential, competitive landscape, and any regulatory or economic factors that could impact the business. Some of the essential points regarding Wave Life's research are outlined below:
| Wave Life Sciences is way too risky over 90 days horizon | |
| Wave Life Sciences appears to be risky and price may revert if volatility continues | |
| The company reported the last year's revenue of 113.31 M. Reported Net Loss for the year was (57.51 M) with loss before taxes, overhead, and interest of (73.64 M). | |
| Wave Life Sciences has about 148.16 M in cash with (19.43 M) of positive cash flow from operations. This results in cash-per-share (CPS) ratio of 1.71. | |
| Wave Life Sciences has a poor financial position based on the latest SEC disclosures | |
| Over 78.0% of the company outstanding shares are owned by institutional investors | |
| Latest headline from finance.yahoo.com: Anti-drone Market is Predicted to Evolve at an Impressive 28.1 percent CAGR through 2031 SkyQuest Technology |
Wave Life uses earnings reports to provide investors with an update of all three financial statements, including the income statement, the balance sheet, and the cash flow statement. Therefore, it is also crucial when considering investing in Wave Life Sciences. Every quarterly earnings report provides investors with an overview of sales, expenses, and net income for the most recent period. It also may provide a comparison to Wave Life's previous reporting period. The quarterly earnings reports are usually disseminated to the public via Form 10-Q, which is a legal document filed with the Securities and Exchange Commission every quarter.
| 27th of March 2024 Upcoming Quarterly Report | View | |
| 1st of May 2024 Next Financial Report | View | |
| 31st of December 2023 Next Fiscal Quarter End | View | |
| 27th of March 2024 Next Fiscal Year End | View | |
| 30th of September 2023 Last Quarter Report | View | |
| 31st of December 2022 Last Financial Announcement | View |
Earnings surprises can significantly impact Wave Life's stock price both in the short term and over time. Negative earnings surprises usually result in a price decline. However, it has been seen that positive earnings surprises lead to an immediate rise in a stock's price and a gradual increase over time. This is why we often hear news about some companies beating earning projections. Financial analysts spend a large amount of time predicting earnings per share (EPS) along with other important future indicators. Many analysts use forecasting models, management guidance, and additional fundamental information to derive an EPS estimate. Below are the table of largest EPS Surprises Wave Life's investors have experienced.
| Reported | Fiscal Date | Estimated EPS | Reported EPS | Surprise | |||
|---|---|---|---|---|---|---|---|
2024-05-09 | 2024-03-31 | -0.21 | -0.24 | -0.03 | 14 | ||
2024-08-08 | 2024-06-30 | -0.21 | -0.25 | -0.04 | 19 | ||
2023-03-22 | 2022-12-31 | -0.41 | -0.47 | -0.06 | 14 | ||
2022-05-12 | 2022-03-31 | -0.56 | -0.62 | -0.06 | 10 | ||
2024-03-06 | 2023-12-31 | -0.23 | -0.15 | 0.08 | 34 | ||
2022-11-10 | 2022-09-30 | -0.5 | -0.42 | 0.08 | 16 | ||
2022-08-11 | 2022-06-30 | -0.54 | -0.62 | -0.08 | 14 | ||
2022-03-03 | 2021-12-31 | -0.51 | -0.61 | -0.1 | 19 |
Know Wave Life's Top Institutional Investors
Have you ever been surprised when a price of an equity instrument such as Wave Life is soaring high without any particular reason? This is usually happening because many institutional investors are aggressively trading Wave Life Sciences backward and forwards among themselves. Wave Life's institutional investor refers to the entity that pools money to purchase Wave Life's securities or originate loans. Institutional investors include commercial and private banks, credit unions, insurance companies, pension funds, hedge funds, endowments, and mutual funds. Operating companies that invest excess capital in these types of assets may also be included in the term and may influence corporate governance by exercising voting rights in their investments.
| Shares | Primecap Management Company | 2024-09-30 | 2.6 M | Geode Capital Management, Llc | 2024-09-30 | 2.3 M | State Street Corp | 2024-06-30 | 2.3 M | Emerald Mutual Fund Advisers Trust | 2024-09-30 | 2.1 M | Artisan Partners Limited Partnership | 2024-09-30 | 2 M | Morgan Stanley - Brokerage Accounts | 2024-06-30 | 1.7 M | Millennium Management Llc | 2024-06-30 | 1.7 M | Fmr Inc | 2024-09-30 | 1.5 M | T. Rowe Price Associates, Inc. | 2024-06-30 | 1.4 M | Ra Capital Management, Llc | 2024-09-30 | 18.2 M | Maverick Capital Ltd | 2024-09-30 | 10 M |
Wave Life's market capitalization trends
The company currently falls under 'Mid-Cap' category with a total capitalization of 2.29 B.Market Cap |
|
Wave Life's profitablity analysis
| Last Reported | Projected for Next Year | ||
| Return On Tangible Assets | (0.21) | (0.22) | |
| Return On Capital Employed | (0.77) | (0.81) | |
| Return On Assets | (0.21) | (0.22) | |
| Return On Equity | (1.21) | (1.27) |
Determining Wave Life's profitability involves analyzing its financial statements and using various financial metrics to determine if Wave Life is a good buy. For example, gross profit margin measures Wave Life's profitability after accounting for the cost of goods sold, while net profit margin measures profitability after accounting for all expenses. Other important metrics include return on assets, return on equity, and free cash flow. By reviewing multiple sources and metrics, you can gain a complete picture of Wave Life's profitability and make more informed investment decisions.
Please note, the presentation of Wave Life's financial position, as portrayed in its financial statements, is often influenced by management's estimates, judgments, and sometimes even manipulations. In the best case, Wave Life's management is honest, while the outside auditors are strict and uncompromising. Please utilize our Beneish M Score to check the likelihood of Wave Life's management manipulating its earnings.
Evaluate Wave Life's management efficiency
Wave Life Sciences has Return on Asset of (0.3404) % which means that on every $100 spent on assets, it lost $0.3404. This is way below average. In the same way, it shows a return on shareholders' equity (ROE) of (2.4382) %, meaning that it generated no profit with money invested by stockholders. Wave Life's management efficiency ratios could be used to measure how well Wave Life manages its routine affairs as well as how well it operates its assets and liabilities. As of November 29, 2024, Return On Tangible Assets is expected to decline to -0.22. In addition to that, Return On Capital Employed is expected to decline to -0.81. At present, Wave Life's Non Currrent Assets Other are projected to increase significantly based on the last few years of reporting. The current year's Fixed Asset Turnover is expected to grow to 3.33, whereas Other Assets are forecasted to decline to about 4.1 M.| Last Reported | Projected for Next Year | ||
| Book Value Per Share | 0.45 | 0.43 | |
| Tangible Book Value Per Share | 0.45 | 0.43 | |
| Enterprise Value Over EBITDA | (6.25) | (6.56) | |
| Price Book Value Ratio | 11.28 | 16.29 | |
| Enterprise Value Multiple | (6.25) | (6.56) | |
| Price Fair Value | 11.28 | 16.29 | |
| Enterprise Value | 422.7 M | 414.9 M |
The leadership approach at Wave Life's fosters a culture of excellence and accountability. Our analysis examines how this culture influences financial outcomes and stock valuation.
Beta (1.21) |
Basic technical analysis of Wave Stock
As of the 29th of November, Wave Life maintains the Downside Deviation of 3.94, market risk adjusted performance of 0.5819, and Mean Deviation of 5.79. Relative to fundamental indicators, the technical analysis model lets you check existing technical drivers of Wave Life Sciences, as well as the relationship between them. Please check out Wave Life Sciences coefficient of variation, as well as the relationship between the treynor ratio and semi variance to decide if Wave Life Sciences is priced fairly, providing market reflects its latest price of 14.99 per share. Given that Wave Life Sciences has jensen alpha of 1.61, we strongly advise you to confirm Wave Life Sciences's prevalent market performance to make sure the company can sustain itself at a future point.Wave Life's insider trading activities
Some recent studies suggest that insider trading raises the cost of capital for securities issuers and decreases overall economic growth. Trading by specific Wave Life insiders, such as employees or executives, is commonly permitted as long as it does not rely on Wave Life's material information that is not in the public domain. Local jurisdictions usually require such trading to be reported in order to monitor insider transactions. In many U.S. states, trading conducted by corporate officers, key employees, directors, or significant shareholders must be reported to the regulator or publicly disclosed, usually within a few business days of the trade. In these cases Wave Life insiders are required to file a Form 4 with the U.S. Securities and Exchange Commission (SEC) when buying or selling shares of their own companies.
Chandra Vargeese over three months ago Acquisition by Chandra Vargeese of 50000 shares of Wave Life at 10.48 subject to Rule 16b-3 | ||
Adrian Rawcliffe over six months ago Acquisition by Adrian Rawcliffe of 45000 shares of Wave Life at 4.58 subject to Rule 16b-3 | ||
Chandra Vargeese over six months ago Acquisition by Chandra Vargeese of 361700 shares of Wave Life subject to Rule 16b-3 | ||
Ken Takanashi over a year ago Acquisition by Ken Takanashi of 45000 shares of Wave Life subject to Rule 16b-3 | ||
Chandra Vargeese over a year ago Sale by Chandra Vargeese of 10249 shares of Wave Life |
Wave Life's Outstanding Corporate Bonds
Wave Life issues bonds to finance its operations. Corporate bonds make up one of the largest components of the U.S. bond market, which is considered the world's largest securities market. Wave Life Sciences uses the proceeds from bond sales for a wide variety of purposes, including financing ongoing mergers and acquisitions, buying new equipment, investing in research and development, buying back their own stock, paying dividends to shareholders, and even refinancing existing debt. Most Wave bonds can be classified according to their maturity, which is the date when Wave Life Sciences has to pay back the principal to investors. Maturities can be short-term, medium-term, or long-term (more than ten years). Longer-term bonds usually offer higher interest rates but may entail additional risks.
| MPLX LP 52 Corp BondUS55336VAL45 | View | |
| Morgan Stanley 3591 Corp BondUS61744YAK47 | View |
Understand Wave Life's technical and predictive indicators
Using predictive indicators to make investment decisions involves analyzing Wave Life's various financial and market-based factors to help forecast future trends and identify investment opportunities. Select the indicators that are most relevant to your investment strategy. Each indicator has its own strengths and weaknesses, so it's essential to combine multiple indicators to get a more comprehensive view of the market and reduce the risk of making poor decisions based on limited data.
| Risk Adjusted Performance | 0.138 | |||
| Market Risk Adjusted Performance | 0.5819 | |||
| Mean Deviation | 5.79 | |||
| Semi Deviation | 3.09 | |||
| Downside Deviation | 3.94 | |||
| Coefficient Of Variation | 595.9 | |||
| Standard Deviation | 12.07 | |||
| Variance | 145.68 | |||
| Information Ratio | 0.1574 | |||
| Jensen Alpha | 1.61 | |||
| Total Risk Alpha | 0.1982 | |||
| Sortino Ratio | 0.4822 | |||
| Treynor Ratio | 0.5719 | |||
| Maximum Drawdown | 82.93 | |||
| Value At Risk | (6.00) | |||
| Potential Upside | 10.86 | |||
| Downside Variance | 15.52 | |||
| Semi Variance | 9.56 | |||
| Expected Short fall | (8.46) | |||
| Skewness | 4.57 | |||
| Kurtosis | 23.91 |
| Risk Adjusted Performance | 0.138 | |||
| Market Risk Adjusted Performance | 0.5819 | |||
| Mean Deviation | 5.79 | |||
| Semi Deviation | 3.09 | |||
| Downside Deviation | 3.94 | |||
| Coefficient Of Variation | 595.9 | |||
| Standard Deviation | 12.07 | |||
| Variance | 145.68 | |||
| Information Ratio | 0.1574 | |||
| Jensen Alpha | 1.61 | |||
| Total Risk Alpha | 0.1982 | |||
| Sortino Ratio | 0.4822 | |||
| Treynor Ratio | 0.5719 | |||
| Maximum Drawdown | 82.93 | |||
| Value At Risk | (6.00) | |||
| Potential Upside | 10.86 | |||
| Downside Variance | 15.52 | |||
| Semi Variance | 9.56 | |||
| Expected Short fall | (8.46) | |||
| Skewness | 4.57 | |||
| Kurtosis | 23.91 |
Consider Wave Life's intraday indicators
Wave Life intraday indicators are useful technical analysis tools used by many experienced traders. Just like the conventional technical analysis, daily indicators help intraday investors to analyze the price movement with the timing of Wave Life stock daily movement. By combining multiple daily indicators into a single trading strategy, you can limit your risk while still earning strong returns on your managed positions.
Wave Life Corporate Filings
F4 | 27th of November 2024 The report filed by a party regarding the acquisition or disposition of a company's common stock, as well as derivative securities such as options, warrants, and convertible securities | ViewVerify |
8K | 20th of November 2024 Report filed with the SEC to announce major events that shareholders should know about | ViewVerify |
ASR | 12th of November 2024 Automatic Shelf Registration Statement under Rule 415 filed with the U.S. Securities and Exchange Commission (SEC) | ViewVerify |
13A | 8th of November 2024 The form used by investors holding more than 5% of a company's stock, to report their beneficial ownership pursuant to Rule 13d-1 or Rule 13d-2 under the Securities Exchange Act of 1934 | ViewVerify |
Wave Stock media impact
Far too much social signal, news, headlines, and media speculation about Wave Life that are available to investors today. That information is available publicly through Wave media outlets and privately through word of mouth or via Wave internal channels. However, regardless of the origin, that massive amount of Wave data is challenging to quantify into actionable patterns, especially for investors that are not very sophisticated with ever-evolving tools and techniques used in the investment management field.
A primary focus of Wave Life news analysis is to determine if its current price reflects all relevant headlines and social signals impacting the current market conditions. A news analyst typically looks at the history of Wave Life relative headlines and hype rather than examining external drivers such as technical or fundamental data. It is believed that price action tends to repeat itself due to investors' collective, patterned thinking related to Wave Life's headlines and news coverage data. This data is often completely overlooked or insufficiently analyzed for actionable insights to drive Wave Life alpha.
Wave Life Sentiment by Major News Outlets
Investor sentiment, mood or attitude towards Wave Life can have a significant impact on its stock price or the market as a whole. This sentiment can be positive or negative, and various factors, such as economic indicators, news events, or market trends, can influence it. When investor sentiment is positive, investors are more likely to buy stocks, increasing demand and increasing the stock price. Positive investor sentiment can be driven by good news about the company or the broader market, such as solid earnings reports or positive economic data.
Note that negative investor sentiment can cause investors to sell stocks, leading to a decrease in demand and a drop in the stock price. Negative sentiment can be driven by factors such as poor earnings reports, negative news about the company or industry, or broader economic concerns. It's important to note that investor sentiment is just one of many factors that can affect stock prices. Other factors, such as company performance, industry trends, and global economic conditions, can also play a significant role in determining the value of a stock.
Wave Life Corporate Management
| Kate Rausch | Investor Relations | Profile | |
| Stephen Lake | VP Devel | Profile | |
| Linda JD | Senior Counsel | Profile | |
| Erik MD | Chief Officer | Profile | |
| Sridhar Vaddeboina | Manufacturing Chemistry | Profile | |
| MBA MD | CEO Pres | Profile | |
| HsiuChiung Yang | Senior Medicine | Profile |
Already Invested in Wave Life Sciences?
The danger of trading Wave Life Sciences is mainly related to its market volatility and Company specific events. As an investor, you must understand the concept of risk-adjusted return before you start trading. The most common way to measure the risk of Wave Life is by using the Sharpe ratio. The ratio expresses how much excess return you acquire for the extra volatility you endure for holding a more risker asset than Wave Life. The Sharpe ratio is calculated by using standard deviation and excess return to determine reward per unit of risk. To understand how volatile Wave Life Sciences is, you must compare it to a benchmark. Traditionally, the risk-free rate of return is the rate of return on the shortest-dated U.S. Treasury, such as a 3-year bond.
When determining whether Wave Life Sciences is a strong investment it is important to analyze Wave Life's competitive position within its industry, examining market share, product or service uniqueness, and competitive advantages. Beyond financials and market position, potential investors should also consider broader economic conditions, industry trends, and any regulatory or geopolitical factors that may impact Wave Life's future performance. For an informed investment choice regarding Wave Stock, refer to the following important reports: Check out Your Current Watchlist to better understand how to build diversified portfolios, which includes a position in Wave Life Sciences. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in real. You can also try the Equity Analysis module to research over 250,000 global equities including funds, stocks and ETFs to find investment opportunities.
Is Pharmaceuticals space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Wave Life. If investors know Wave will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Wave Life listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Earnings Share (1.12) | Revenue Per Share 0.427 | Quarterly Revenue Growth (0.11) | Return On Assets (0.34) | Return On Equity (2.44) |
The market value of Wave Life Sciences is measured differently than its book value, which is the value of Wave that is recorded on the company's balance sheet. Investors also form their own opinion of Wave Life's value that differs from its market value or its book value, called intrinsic value, which is Wave Life's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Wave Life's market value can be influenced by many factors that don't directly affect Wave Life's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
In summary, please note that there is a difference between Wave Life's value and its price, as these two are different measures arrived at by various means. Investors typically determine if Wave Life is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Wave Life's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.